Back
Viridian Therapeutics Stock Price Chart
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
VRDN
Viridian Therapeutics
Last Price:
$12.38
Seasonality Move:
-1.83%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.
Viridian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.94 | Sell |
| 20-day SMA: | 13.08 | Sell |
| 50-day SMA: | 13.88 | Sell |
| 200-day SMA: | 17.94 | Sell |
| 8-day EMA: | 12.78 | Sell |
| 20-day EMA: | 13.05 | Sell |
| 50-day EMA: | 14.05 | Sell |
| 200-day EMA: | 16.72 | Sell |
Viridian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 42.2 | Sell |
| Chaikin Money Flow: | -604630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12 - 13.56) | Sell |
| Bollinger Bands (100): | (13.48 - 18.9) | Sell |
Viridian Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics Stock
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 12.39 while VRDN 8-day simple moving average is 12.94, which is a Sell signal.
-
The stock price of VRDN is 12.39 while Viridian Therapeutics 20-day SMA is 13.08, which makes it a Sell.
-
Viridian Therapeutics 50-day simple moving average is 13.88 while VRDN share price is 12.39, making it a Sell technically.
-
VRDN stock price is 12.39 and Viridian Therapeutics 200-day simple moving average is 17.94, creating a Sell signal.
VRDN Technical Analysis vs Fundamental Analysis
Sell
18
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a SellThe current Viridian Therapeutics [VRDN] share price is $12.39. The Score for VRDN is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Viridian Therapeutics Stock Info
Market Cap:
1B
Price in USD:
12.39
Share Volume:
655.7K
Viridian Therapeutics 52-Week Range
52-Week High:
27.20
52-Week Low:
9.90
Sell
18
Viridian Therapeutics (VRDN)
is a Sell
Viridian Therapeutics Share Price Forecast
-
What is the Viridian Therapeutics stock price today?The Viridian Therapeutics stock price is 12.39 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics is overvalued.
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 12.39 while VRDN 8-day exponential moving average is 12.78, which is a Sell signal.
-
The stock price of VRDN is 12.39 while Viridian Therapeutics 20-day EMA is 13.05, which makes it a Sell.
-
Viridian Therapeutics 50-day exponential moving average is 14.05 while VRDN share price is 12.39, making it a Sell technically.
-
VRDN stock price is 12.39 and Viridian Therapeutics 200-day simple moving average is 16.72, creating a Sell signal.
Fundamental Analysis of Viridian Therapeutics
Is Viridian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.11 per share, and an increase next year of $0.26 per share.
Technical Analysis of Viridian Therapeutics
Should I short Viridian Therapeutics stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Viridian Therapeutics is a Sell
-
Viridian Therapeutics Relative Strength Index (RSI) is 42.2, which suggest Viridian Therapeutics is oversold
-
The Bollinger Bands (25) for Viridian Therapeutics is (12 - 13.56), which suggest Viridian Therapeutics is a Sell
-
The Bollinger Bands (100) for Viridian Therapeutics is (13.48 - 18.9), which suggest Viridian Therapeutics is a Sell
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.